Skip to main content

Table 4 Genotype and allele frequencies of polymorphisms in the CYP3A5, CYP2D6, ABCG2, ABCB1, and OATP1B1

From: Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study

 

Genotype

Number (%)

Allele frequency

CYP3A5*3

*1/*1

1 (0.06)

*1

0.22

*1/*3

6 (0.33)

*3

0.78

*3/*3

11 (0.61)

  

CYP2D6*5 and *10

*1/*1

4 (0.22)

*1

0.47

*1/*5

1 (0.06)

*5

0.06

*1/*10

8 (0.44)

*10

0.47

*5/*10

1 (0.06)

  

*10/*10

4 (0.22)

  

ABCG2 421C > A

C/C

8 (0.44)

C

0.64

C/A

7 (0.39)

A

0.36

A/A

3 (0.17)

  

ABCB1 1236C > T

C/C

4 (0.22)

C

0.53

C/T

11 (0.61)

T

0.47

T/T

3 (0.17)

  

ABCB1 2677G > T/A

G/G

1 (0.06)

G

0.28

G/T

7 (0.38)

T

0.61

G/A

1 (0.06)

A

0.11

T/T

6 (0.33)

  

T/A

3 (0.17)

  

ABCB1 3435C > T

C/C

1 (0.06)

C

0.25

C/T

7 (0.38)

T

0.75

T/T

10 (0.56)

  

OATP1B1 388A > G

A/A

3 (0.17)

A

0.36

A/G

7 (0.38)

G

0.64

G/G

8 (0.44)

  

OATP1B1 521 T > C

T/T

13 (0.72)

T

0.83

T/C

4 (0.22)

C

0.17

C/C

1 (0.06)

  

OATP1B1 diplotype

*1a/*1a

3 (0.17)

  

*1a/*1b

4 (0.22)

  

*1b/*1b

6 (0.33)

  

*1a/*15

3 (0.17)

  

*1b/*15

1 (0.06)

  

*15/*15

1 (0.06)

  
  1. N = 18